Stephen J. Forman, Director at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT), bought 42,106 shares at $4.75 ($200K) on 2020-11-30, disclosed to the SEC on 2020-12-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.75 | 21,053 | $100K | 50.0% |
| 2 | $4.75 | 21,053 | $100K | 50.0% |
| Total | $4.75 avg | 42,106 | $200K | 100% |